ID

15283

Description

Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01697657

Link

https://clinicaltrials.gov/show/NCT01697657

Keywords

  1. 5/24/16 5/24/16 -
Uploaded on

May 24, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT01697657

Eligibility Diabetes NCT01697657

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697657
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 1 diabetes
Description

type 1 diabetes

Data type

boolean

Alias
UMLS CUI [1]
C0011854
fasting c-peptide below lower limit of normal fasting range
Description

fasting c-peptide

Data type

boolean

Alias
UMLS CUI [1]
C2208720
duration of type 1 diabetes for at least 12 months
Description

duration of diabetes

Data type

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0011854
current treatment: basal - bolus regimen for at least 4 months with intermediate or long-acting insulin once, twice or three times daily as basal insulin and 3-4 premeal insulin aspart or lispro injections
Description

current treatment

Data type

boolean

Alias
UMLS CUI [1]
C0087111
hba1c maximum 9.0% (using biorad variant method)
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
able and willing to perform self-monitoring of blood glucose
Description

blood glucose

Data type

boolean

Alias
UMLS CUI [1]
C0202042
basal insulin requirement at least 30% of the total daily insulin dose
Description

basal insulin requirement

Data type

boolean

Alias
UMLS CUI [1]
C0650607
bmi (body mass index) maximum 35 kg/m^2
Description

BMI

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
proliferative retinopathy or maculopathy requiring acute treatment
Description

retinopathy or maculopathy

Data type

boolean

Alias
UMLS CUI [1]
C0035309
UMLS CUI [2]
C0730362
total daily insulin dose above 1.4 iu/kg/day
Description

insulin dose

Data type

boolean

Alias
UMLS CUI [1]
C0021641
known unawareness of hypoglycaemia
Description

unawareness of hypoglycaemia

Data type

boolean

Alias
UMLS CUI [1]
C0342317
impaired hepatic function
Description

impaired hepatic function

Data type

boolean

Alias
UMLS CUI [1]
C0232741
impaired renal function
Description

impaired renal function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
cardiac problems
Description

cardiac problems

Data type

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled, treated/untreated hypertension
Description

hypertension

Data type

boolean

Alias
UMLS CUI [1]
C0020538
known or suspected allergy to trial product or related products
Description

allergy to trial product

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006

Similar models

Eligibility Diabetes NCT01697657

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697657
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
type 1 diabetes
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
fasting c-peptide
Item
fasting c-peptide below lower limit of normal fasting range
boolean
C2208720 (UMLS CUI [1])
duration of diabetes
Item
duration of type 1 diabetes for at least 12 months
boolean
C0872146 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
current treatment
Item
current treatment: basal - bolus regimen for at least 4 months with intermediate or long-acting insulin once, twice or three times daily as basal insulin and 3-4 premeal insulin aspart or lispro injections
boolean
C0087111 (UMLS CUI [1])
hba1c
Item
hba1c maximum 9.0% (using biorad variant method)
boolean
C0019018 (UMLS CUI [1])
blood glucose
Item
able and willing to perform self-monitoring of blood glucose
boolean
C0202042 (UMLS CUI [1])
basal insulin requirement
Item
basal insulin requirement at least 30% of the total daily insulin dose
boolean
C0650607 (UMLS CUI [1])
BMI
Item
bmi (body mass index) maximum 35 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
retinopathy or maculopathy
Item
proliferative retinopathy or maculopathy requiring acute treatment
boolean
C0035309 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
insulin dose
Item
total daily insulin dose above 1.4 iu/kg/day
boolean
C0021641 (UMLS CUI [1])
unawareness of hypoglycaemia
Item
known unawareness of hypoglycaemia
boolean
C0342317 (UMLS CUI [1])
impaired hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled, treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial